open access

Vol 68, No 3 (2018)
Original articles
Get Citation

Surgical treatment of rectal cancer in Poland — a report from a prospective, multi-centre observational study PSSO_01 conducted under the auspices of the Polish Society of Surgical Oncology

Tomasz Błaszkowski, Grzegorz Celban, Maciej Domagała, Jarosław Janas, Michał Jankowski, Józef Kładny, Wiesław Janusz Kruszewski, Konrad Listwan, Zbigniew Lorenc, Anna Madej-Mierzwa, Adam Majewski, Marek Mądrecki, Jerzy Mielko, Sebastian Mosiej, Piotr Nowaczyk, Mariusz Obrębski, Tomasz Olesiński, Piotr Papaj, Oskar Pelzer, Paweł Pius, Wojciech Polkowski, Karol Rawicz-Pruszyński, Andrzej Rutkowski, Karol Tkaczyński, Dorian Wiśniewski, Wojciech Woźny, Józef Wróbel, Wojciech M. Wysocki, Wojciech Zegarski
Nowotwory. Journal of Oncology 2018;68(3):118-126.

open access

Vol 68, No 3 (2018)
Original articles

Abstract

Introduction. Since 2016, as part of the PSSO_01 multi-centre research project conducted under the auspices of the Polish Society of Surgical Oncology, clinical data on rectal cancer treatment have been collected. The objective of the study was to illustrate the state of early results of surgical treatment. Material and methods. The research project is multi-centre in nature. Data shall be collected electronically. The study protocol does not impose or suggest any course of procedure. It only systematizes the way data are collected for scientific purposes. The analysis of early results of surgical treatment was compared with the results of population studies from other European countries (Netherlands, Belgium). Results. By the end of June 2018, 736 patients were registered in the study. In 399 (54.2%) an anterior resection was performed. More than half of patients undergoing subsequent surgical treatment (54.2%) receive neoadjuvant treatment, with the percentage of patients undergoing radiotherapy or radiochemical treatment for lower rectal cancer being about 70%. Most patients (96%) are operated in elective procedure. The percentage of laparoscopic surgeries is low (8.6%). Postoperative complications are observed in 21.1% of patients. Severe complications (grades III–V according to Clavien-Dindo classification) occur in 7.6% of patients undergoing surgery. Postoperative mortality is 1.1%. Discussion. Although the project does not have the character of a registry and does not allow for drawing wider conclusions concerning the compliance with the standards of qualification for neoadjuvant treatment, the important information is that more than half of rectal cancer patients receive preoperative treatment, and the percentage of severe postoperative complications does not exceed 10%. Conclusions. The results of the PSSO_01 project are representative and reflect the actual situation concerning surgical treatment of rectal cancer patients in Poland.

Abstract

Introduction. Since 2016, as part of the PSSO_01 multi-centre research project conducted under the auspices of the Polish Society of Surgical Oncology, clinical data on rectal cancer treatment have been collected. The objective of the study was to illustrate the state of early results of surgical treatment. Material and methods. The research project is multi-centre in nature. Data shall be collected electronically. The study protocol does not impose or suggest any course of procedure. It only systematizes the way data are collected for scientific purposes. The analysis of early results of surgical treatment was compared with the results of population studies from other European countries (Netherlands, Belgium). Results. By the end of June 2018, 736 patients were registered in the study. In 399 (54.2%) an anterior resection was performed. More than half of patients undergoing subsequent surgical treatment (54.2%) receive neoadjuvant treatment, with the percentage of patients undergoing radiotherapy or radiochemical treatment for lower rectal cancer being about 70%. Most patients (96%) are operated in elective procedure. The percentage of laparoscopic surgeries is low (8.6%). Postoperative complications are observed in 21.1% of patients. Severe complications (grades III–V according to Clavien-Dindo classification) occur in 7.6% of patients undergoing surgery. Postoperative mortality is 1.1%. Discussion. Although the project does not have the character of a registry and does not allow for drawing wider conclusions concerning the compliance with the standards of qualification for neoadjuvant treatment, the important information is that more than half of rectal cancer patients receive preoperative treatment, and the percentage of severe postoperative complications does not exceed 10%. Conclusions. The results of the PSSO_01 project are representative and reflect the actual situation concerning surgical treatment of rectal cancer patients in Poland.

Get Citation

Keywords

rectal cancer, PSSO, surgical treatment

About this article
Title

Surgical treatment of rectal cancer in Poland — a report from a prospective, multi-centre observational study PSSO_01 conducted under the auspices of the Polish Society of Surgical Oncology

Journal

Nowotwory. Journal of Oncology

Issue

Vol 68, No 3 (2018)

Pages

118-126

Bibliographic record

Nowotwory. Journal of Oncology 2018;68(3):118-126.

Keywords

rectal cancer
PSSO
surgical treatment

Authors

Tomasz Błaszkowski
Grzegorz Celban
Maciej Domagała
Jarosław Janas
Michał Jankowski
Józef Kładny
Wiesław Janusz Kruszewski
Konrad Listwan
Zbigniew Lorenc
Anna Madej-Mierzwa
Adam Majewski
Marek Mądrecki
Jerzy Mielko
Sebastian Mosiej
Piotr Nowaczyk
Mariusz Obrębski
Tomasz Olesiński
Piotr Papaj
Oskar Pelzer
Paweł Pius
Wojciech Polkowski
Karol Rawicz-Pruszyński
Andrzej Rutkowski
Karol Tkaczyński
Dorian Wiśniewski
Wojciech Woźny
Józef Wróbel
Wojciech M. Wysocki
Wojciech Zegarski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Nowotwory. Journal of Oncology dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl